TVRD
Tvardi Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.80 / 10
Netural
Fund flow analysis scores 7.58/10, indicating robust fund flow characteristics. Bullish trends in overall, block, Small, Medium, Large, and Extra-large contrast with bearish signals in no significant trends, suggesting positive liquidity momentum. Analyst sentiment reflects cautiously optimistic analyst perspective with balanced view. The rating profile includes Strong Buy(33.3%), Neutral(66.7%) from 3 analytical reports, supported by 4.03 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
33%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Etzer DaroutNeutral
Date2026-04-01
InstitutionBarclays
Times predicted2
Historical Win Rate50.0%
Julian HarrisonStrong Buy
Yasmeen RahimiNeutral
What is the market sentiment for TVRD?
- TVRD holds a Bearish analyst rating, with 33% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.80/10 (Netural).
